NO904149L - Fremgangsmaate og forbindelser for tilfoersel av aica-ribosid for nedsettelse av glukosekonsentrasjonen i blod. - Google Patents

Fremgangsmaate og forbindelser for tilfoersel av aica-ribosid for nedsettelse av glukosekonsentrasjonen i blod.

Info

Publication number
NO904149L
NO904149L NO90904149A NO904149A NO904149L NO 904149 L NO904149 L NO 904149L NO 90904149 A NO90904149 A NO 90904149A NO 904149 A NO904149 A NO 904149A NO 904149 L NO904149 L NO 904149L
Authority
NO
Norway
Prior art keywords
aica riboside
relationships
blood
procedure
supply
Prior art date
Application number
NO90904149A
Other languages
English (en)
Norwegian (no)
Other versions
NO904149D0 (no
Inventor
Harry E Gruber
Ronald E Tuttle
Clinton E Browne
Bheemarao G Ugarkar
Jack W Reich
Ernest Kurt Metzner
Paul J Marangos
Original Assignee
Gensia Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/301,222 external-priority patent/US5082829A/en
Priority claimed from US07/301,453 external-priority patent/US5200525A/en
Application filed by Gensia Pharma filed Critical Gensia Pharma
Publication of NO904149D0 publication Critical patent/NO904149D0/no
Publication of NO904149L publication Critical patent/NO904149L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • External Artificial Organs (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Prostheses (AREA)
NO90904149A 1989-01-24 1990-09-24 Fremgangsmaate og forbindelser for tilfoersel av aica-ribosid for nedsettelse av glukosekonsentrasjonen i blod. NO904149L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/301,222 US5082829A (en) 1989-01-24 1989-01-24 AICA riboside prodrugs
US07/301,453 US5200525A (en) 1989-01-24 1989-01-24 Anti-seizure compounds
US40810789A 1989-09-15 1989-09-15
PCT/US1990/000359 WO1990009163A2 (en) 1989-01-24 1990-01-24 Method and compounds for aica riboside delivery and for lowering blood glucose

Publications (2)

Publication Number Publication Date
NO904149D0 NO904149D0 (no) 1990-09-24
NO904149L true NO904149L (no) 1990-11-26

Family

ID=27404800

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90904149A NO904149L (no) 1989-01-24 1990-09-24 Fremgangsmaate og forbindelser for tilfoersel av aica-ribosid for nedsettelse av glukosekonsentrasjonen i blod.

Country Status (13)

Country Link
EP (1) EP0427799B1 (de)
JP (1) JPH03504728A (de)
KR (1) KR910700057A (de)
AT (1) ATE114474T1 (de)
AU (2) AU5086190A (de)
CA (1) CA2008325A1 (de)
DE (1) DE69014562T2 (de)
DK (1) DK0427799T3 (de)
FI (1) FI904694A0 (de)
IE (1) IE75372B1 (de)
IL (1) IL93164A0 (de)
NO (1) NO904149L (de)
WO (1) WO1990009163A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5214048A (en) * 1987-05-19 1993-05-25 Nippon Kayaku Kabushiki Kaisha Oxetanocins
US5736531A (en) * 1987-10-28 1998-04-07 Pro-Neuron, Inc. Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides
US7776838B1 (en) 1987-10-28 2010-08-17 Wellstat Therapeutics Corporation Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
US5968914A (en) * 1987-10-28 1999-10-19 Pro-Neuron, Inc. Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
US5202459A (en) * 1989-11-07 1993-04-13 Nippon Kayaku Kabushiki Kaisha Process for producing cyclobutane derivative
JPH0615556B2 (ja) * 1989-11-10 1994-03-02 旭化成工業株式会社 ４―カルバモイル―１―β―Ｄ―リボフラノシル―イミダゾリウム―５―オレイト無水結晶
US5324730A (en) * 1990-05-24 1994-06-28 Nippon Kayaku Kabushiki Kaisha Phenoxyphosphoryloxymethyl cyclobutyl purines
IL99124A (en) * 1990-08-10 1998-02-22 Gensia Pharma Substituted imidazole analogs of aica riboside
US5236908A (en) * 1991-06-07 1993-08-17 Gensia Pharmaceuticals, Inc. Methods of treating injury to the central nervous system
IL103294A0 (en) * 1991-09-30 1993-05-13 Gensia Pharma Pharmaceutical compositions for preventing tissue damage associated with decreased blood flow
IL108523A0 (en) * 1993-02-03 1994-05-30 Gensia Inc Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain
RU2153873C2 (ru) * 1994-08-09 2000-08-10 Кортендо АБ Применение кетоконазола и родственных веществ в лекарствах, предназначенных для лечения диабета типа ii
DE69819311T2 (de) 1997-03-07 2004-07-29 Metabasis Therapeutics Inc., San Diego Neue benzimidazol inhibitoren der fructose-1,6-bisphosphatase
US6054587A (en) 1997-03-07 2000-04-25 Metabasis Therapeutics, Inc. Indole and azaindole inhibitors of fructose-1,6-bisphosphatase
EP1402895A1 (de) * 1997-03-07 2004-03-31 Metabasis Therapeutics, Inc. Benzimidazolinhibitoren der Fructose 1,6-biphosphatase
US6284748B1 (en) 1997-03-07 2001-09-04 Metabasis Therapeutics, Inc. Purine inhibitors of fructose 1,6-bisphosphatase
US6312662B1 (en) 1998-03-06 2001-11-06 Metabasis Therapeutics, Inc. Prodrugs phosphorus-containing compounds
AU2003242500B2 (en) * 1998-09-09 2006-11-02 Metabasis Therapeutics, Inc. Novel Heteroaromatic Inhibitors of Fructose 1,6-bisphosphatase
CN100349904C (zh) * 1998-09-09 2007-11-21 症变治疗公司 新的果糖1,6－二磷酸酶的杂芳族抑制剂
KR100818845B1 (ko) 1998-09-09 2008-04-01 메타베이시스 테라퓨틱스, 인크. 신규한 프럭토스 1,6-비스포스파타제의 헤테로방향족 억제제
US6756360B1 (en) 1998-12-24 2004-06-29 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
PL352756A1 (en) * 1998-12-24 2003-09-08 Metabasis Therapeutics, Inc. A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes
JP2003525944A (ja) 2000-03-08 2003-09-02 メタバシス・セラピューティクス・インコーポレイテッド 新規アリールフルクトース−１，６−ビスホスファターゼ阻害剤
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
EP1372660A2 (de) * 2000-07-06 2004-01-02 Metabasis Therapeutics, Inc. Fbpase inhibitoren in kombination mit antidiabetika für die behandlung von diabetes
ES2192495B1 (es) 2002-03-21 2005-02-16 Universidad De Barcelona Nuevo uso terapeutico del ribosido de 5-aminoimidazol-4-carboxamida (acadesina).
EP1752450A1 (de) 2005-08-01 2007-02-14 Merck Sante Imidazolderivate als Fruktose-1,6-biphosphataseinhibitoren und pharmazeutische Zusammensetzungen diese enthaltend
WO2008086341A1 (en) * 2007-01-09 2008-07-17 Pericor Therapeutics, Inc. Methods. compositions, and formulations for preventing or reducing adverse effects in a patient
EP2058308A1 (de) 2007-11-12 2009-05-13 Merck Sante Benzimidazoldihydrothiadiazinonderivate als Fructose-1,6-biphosphatase-Hemmer und diese enthaltende pharmazeutische Zusammensetzungen.
JP5591245B2 (ja) * 2008-10-03 2014-09-17 ペリコー セラピューティクス， インコーポレイテッド 急性心不全の治療のための方法および組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1535561A (fr) * 1966-06-18 1968-08-09 Ajinomoto Kk Méthode de préparation de l'adénine, de ses dérivés et intermédiaires
US4575498A (en) * 1983-07-21 1986-03-11 Duke University Method for restoring depleted purine nucleotide pools
AU5668886A (en) * 1986-03-27 1987-10-20 Harry Edward Gruber A method of increasing adenosine excretion
US4912092A (en) * 1986-03-27 1990-03-27 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells

Also Published As

Publication number Publication date
IL93164A0 (en) 1990-11-05
EP0427799A4 (en) 1991-07-24
KR910700057A (ko) 1991-03-13
DK0427799T3 (da) 1995-05-08
WO1990009163A3 (en) 1991-01-24
AU5086190A (en) 1990-09-05
IE75372B1 (en) 1997-09-10
CA2008325A1 (en) 1990-07-24
FI904694A7 (fi) 1990-09-24
JPH03504728A (ja) 1991-10-17
EP0427799B1 (de) 1994-11-30
FI904694A0 (fi) 1990-09-24
DE69014562D1 (de) 1995-01-12
AU5236093A (en) 1994-02-24
DE69014562T2 (de) 1995-06-22
EP0427799A1 (de) 1991-05-22
IE900274L (en) 1990-07-24
ATE114474T1 (de) 1994-12-15
WO1990009163A2 (en) 1990-08-23
NO904149D0 (no) 1990-09-24

Similar Documents

Publication Publication Date Title
NO904149L (no) Fremgangsmaate og forbindelser for tilfoersel av aica-ribosid for nedsettelse av glukosekonsentrasjonen i blod.
PL346520A1 (en) Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
BR9913932A (pt) Uso de análogos de glp-1 no tratamento de derrame
MY124091A (en) Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
DK69090A (da) Forbindelsesstykke med y-form til anvendelse ved angioplastik
AU8970198A (en) N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in thetreatment of pain
IL151248A0 (en) Novel aryl fructose-1,6-bisphosphatase inhibitors
ES2183952T3 (es) Tratamiento de diabetes tipo ii con dosis elevadas de tripicolinato cromico.
NO882853L (no) Korreksjon med dobbeltraadet rna av unormale tilstander i immunkomplekser som er i omloep, og i monocyttfunkjon.
EP0354322A3 (de) Antidiabetische alpha-substituierte Phosphonate
DK36288A (da) Genstand til anvendelse i forbindelse med blod og fremgangsmaaden til fremstilling af genstanden samt dens anvendelse
IT9048057A0 (it) Impiego di uridina nel trattamento farmacologico delle complicazioni periferiche del diabete.
IT1116032B (it) Composizione e procedimento per la determinazione della concentrazione del glucosio in fluidi corporei
MX9205568A (es) Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida.
BR0001794A (pt) Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares)
HK1042852A1 (zh) 增强胰岛素反应的方法
DE69738292D1 (de) Nährungszusammensetzung für sport
IT8349080A0 (it) Pigiama munito di aperture chiudibili per la ispezione corporea, in particolare per pazienti degenti
ATE207357T1 (de) Verwendung von cotinin zur linderung des tabakentzugssyndrom
KR910002456A (ko) 당뇨병 치료용 제약 조성물
FI875470A7 (fi) Vilounderlag foer straolningsenheter.
EP0311467A3 (en) Use of pyrroloû3,2,1-hi¨indole derivatives in the manufacture of a medicament for the treatment of diabetes
IT1241993B (it) Uso di alfa-chetoglurato di arginina e/oppure di diarginina nella preparazione di composizioni farmaceutiche per il trattamento di deficit psicologici, immunologici e dell'apprendimento
TH52878A3 (th) ไธอิโนไพริมิดิน
Senczuk et al. Toxicodynamic propertes of toluidines. Part II. Blood absorption of toluidines.